Literature DB >> 7756482

Aspergillus fungemia: report of two cases and review.

R Duthie1, D W Denning.   

Abstract

We present two cases of aspergillus infection confirmed by blood culture and review 30 other cases of genuine aspergillus fungemia and 34 cases of aspergillus pseudofungemia. Multiple different media and blood culture systems were used to isolated Aspergillus. The median time to positive blood culture was 8.5 days (range, 1-27 days) in the genuine cases. Genuine aspergillus fungemia was observed more often after cardiac surgery (n = 11 [34%]) or during neutropenia (n = 9 [28%]) than in other settings. In a recent series of fungemia during neutropenia, 7.6% of all episodes were due to Aspergillus. Other patients at risk for aspergillus fungemia were similar to those at risk for invasive aspergillosis, including patients with AIDS. Seven (44%) of 19 patients who were treated survived. In the group of patients with aspergillus pseudofungemia, there were no deaths, and cultures of additional specimens from the same patient were not positive. Criteria that may be applied to ascertain whether the isolation of Aspergillus from blood cultures is clinically significant are put forward.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756482     DOI: 10.1093/clinids/20.3.598

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  24 in total

1.  Panfungal PCR and multiplex liquid hybridization for detection of fungi in tissue specimens.

Authors:  P H Hendolin; L Paulin; P Koukila-Kähkölä; V J Anttila; H Malmberg; M Richardson; J Ylikoski
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

Review 2.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

3.  High-throughput identification of clinical pathogenic fungi by hybridization to an oligonucleotide microarray.

Authors:  Aihua Huang; Jun-Wen Li; Zhi-Qiang Shen; Xin-Wei Wang; Min Jin
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

4.  Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis.

Authors:  James I Ito; Joseph M Lyons; Teresa B Hong; Daniel Tamae; Yi-Kuang Liu; Sharon P Wilczynski; Markus Kalkum
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

Review 5.  Cutaneous aspergillosis.

Authors:  J A van Burik; R Colven; D H Spach
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

6.  Steroid-induced invasive aspergillosis with thyroid gland abscess and positive blood cultures.

Authors:  M Vogeser; A Haas; G Ruckdeschel; W von Scheidt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

7.  Detection and identification of fungal pathogens in blood by using molecular probes.

Authors:  H Einsele; H Hebart; G Roller; J Löffler; I Rothenhofer; C A Müller; R A Bowden; J van Burik; D Engelhard; L Kanz; U Schumacher
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

8.  PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients.

Authors:  M E Jones; A J Fox; A J Barnes; B A Oppenheim; P Balagopal; G R Morgenstern; J H Scarffe
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

9.  Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Dieter Buchheidt; Corinna Baust; Heyko Skladny; Wolfgang Seifarth; Udo Zeilfelder; Christine Leib-Mösch; Handan Mörz; Rüdiger Hehlmann
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 10.  Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature.

Authors:  P Eggimann; J-C Chevrolet; M Starobinski; P Majno; M Totsch; B Chapuis; D Pittet
Journal:  Infection       Date:  2006-12       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.